Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
| ERICKSON AIR | EAC | 5.10% |
| ASSURED GUAR | AGO | 4.98% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Rating agencies, A.M. Best Co., Standard & Poor’s Ratings Services (S&P) and Moody’s Investor Services of Moody's Corp. (MCO - Analyst Report) have assigned debt ratings to the newly issued senior unsecured notes of WellPoint Inc. (WLP - Analyst Report). While Moody’s assigned a “Baa2” rating to the notes with a stable outlook, S&P rated these with an “A-”. Additionally, A. M. Best rated the notes “bbb+” and placed these under review with negative implications.
The financial strength ratings (FSR), issuer credit ratings (ICR) and existing debt ratings of WellPoint were also placed under the review, with a negative outlook, by A. M. Best in July 2012. These ratings were placed under review following the company’s announcement of a deal to acquire Amerigroup Corporation (AGP) and are expected to remain under review till the closure of the deal. Meanwhile, A.M. Best will continue evaluating WellPoint’s operating results, capitalization level, capital structure and other relevant metrics, which affect the company’s ratings.
The Amerigroup acquisition is also the reason behind the issuance of these notes. Earlier this week, WellPoint issued 1.25% senior unsecured notes due 2015 worth $625 million, 1.875% senior unsecured notes due 2018 worth $625 million, 3.30% senior unsecured notes due 2023 worth $1 billion and 4.65% senior unsecured notes due 2043 worth $1 billion to partly finance the acquisition. According to Reuters, Citigroup Inc. (C - Analyst Report), Credit Suisse Group (CS - Snapshot Report) and Deutsche Bank AG (DB - Snapshot Report) acted as the book-running managers for the sale.
The $4.9 billion acquisition deal was announced in July this year. WellPoint will pay $92.00 per share to buy all the outstanding shares of Amerigroup. This reflects a 43% premium on Amerigroup’s closing price of $64.34 on July 6. Apart from the proceeds from the issue of the new notes, WellPoint will fund the purchase with its cash reserves and additional borrowings via commercial papers.
WellPoint currently carries a Zacks #4 Rank, which translates into a short-term Sell rating. We maintain a long-term ‘Neutral’ rating on its shares.
Get the full Snapshot Report on CS - FREE
Get the full Analyst Report on WLP - FREE
Get the full Analyst Report on MCO - FREE
Get the full Snapshot Report on DB - FREE
Get the full Analyst Report on C - FREE